CELLS COMPRISING MOGROSIDE PATHWAY ENZYMES AND USES THEREOF

ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME

RECOMBINANT MICROORGANISM FOR PRODUCING CARNOSINE, HISTIDINE AND BETA-ALANINE AND METHOD FOR PRODUCING CARNOSINE, HISTIDINE AND BETA-ALANINE BY USING SAME

Engineered Biosynthetic Pathways for Production of Histamine by Fermentation

ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME

ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME

ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME

ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME

ENHANCED PRODUCTION OF HISTIDINE, PURINE PATHWAY METABOLITES, AND PLASMID DNA

Genetically engineered bacterium for producing L-histidine and use thereof

Cells comprising mogroside pathway enzymes and uses thereof

Engineered biosynthetic pathways for production of histamine by fermentation

ATP phosphoribosyltransferase variant and method for producing L-histidine using the same

Microorganism having increased glycine productivity and method for producing fermented composition using the same

Promoter and a method for producing L-amino acid using the same